{"entity":{"type":"insider","cik":"0001612050","url":"/insider/0001612050","json_url":"/insider/0001612050.json","name":"Livingston Philip O.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":1,"first":"2018-01-16","last":"2018-01-16","span_basis":"filed_date"},"name_variants":[{"name":"Livingston Philip O.","source":"filing","n_filings":1,"first_seen":"2018-01-16","last_seen":"2018-01-16"}],"transactions":[{"id":6791038,"accession":"0001415889-18-000061","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-18-000061","line_url":"/filing/0001415889-18-000061#line-4","is_derivative":false,"issuer_cik":"0001109196","issuer_name":"MABVAX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"MBVX","issuer_name_source":null,"issuer_url":"/issuer/0001109196","owner_cik":"0001612050","owner_name":"Livingston Philip O.","owner_display_name":"Livingston Philip O.","owner_url":"/insider/0001612050","role":"Director, Officer (CHIEF SCIENCE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENCE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3571.0,"shares_display":"3,571","price_per_share":0.96,"price_display":"0.96","price_state":"stated","total_value":3428.16,"total_display":"3,428.16","total_whole":"3,428","shares_owned_after":256554.0,"shares_owned_after_display":"256,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-12","filed_date":"2018-01-16","scope":"insider"},{"id":6791034,"accession":"0001415889-18-000061","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-18-000061","line_url":"/filing/0001415889-18-000061#line-3","is_derivative":false,"issuer_cik":"0001109196","issuer_name":"MABVAX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"MBVX","issuer_name_source":null,"issuer_url":"/issuer/0001109196","owner_cik":"0001612050","owner_name":"Livingston Philip O.","owner_display_name":"Livingston Philip O.","owner_url":"/insider/0001612050","role":"Director, Officer (CHIEF SCIENCE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENCE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12301.0,"shares_display":"12,301","price_per_share":0.98,"price_display":"0.98","price_state":"stated","total_value":12054.98,"total_display":"12,054.98","total_whole":"12,055","shares_owned_after":260125.0,"shares_owned_after_display":"260,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-11","filed_date":"2018-01-16","scope":"insider"},{"id":6791029,"accession":"0001415889-18-000061","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-18-000061","line_url":"/filing/0001415889-18-000061#line-2","is_derivative":false,"issuer_cik":"0001109196","issuer_name":"MABVAX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"MBVX","issuer_name_source":null,"issuer_url":"/issuer/0001109196","owner_cik":"0001612050","owner_name":"Livingston Philip O.","owner_display_name":"Livingston Philip O.","owner_url":"/insider/0001612050","role":"Director, Officer (CHIEF SCIENCE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENCE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21155.0,"shares_display":"21,155","price_per_share":0.96,"price_display":"0.96","price_state":"stated","total_value":20308.8,"total_display":"20,308.80","total_whole":"20,309","shares_owned_after":272426.0,"shares_owned_after_display":"272,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-10","filed_date":"2018-01-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001109196","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","url":"/issuer/0001109196","role":"Director, Officer (CHIEF SCIENCE OFFICER)","n_filings":1,"first_seen":"2018-01-16","last_seen":"2018-01-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001612050","retrieved_at":"2026-08-27T13:35:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}